Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome p450 activities

Citation
S. Koul et al., Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome p450 activities, BIO MED CH, 8(1), 2000, pp. 251-268
Citations number
46
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY
ISSN journal
09680896 → ACNP
Volume
8
Issue
1
Year of publication
2000
Pages
251 - 268
Database
ISI
SICI code
0968-0896(200001)8:1<251:SROPAI>2.0.ZU;2-8
Abstract
Inhibitors of drug metabolism have important implications in pharmaco-toxic ology and agriculture. We have reported earlier that piperine, a major alka loid of black and long peppers inhibits both constitutive and inducible cyt ochrome P450 (CYP)dependent drug metabolising enzymes. In the present study , an attempt has been made to prepare several novel synthetic analogues so as to relate various modifications in the parent molecule to the inhibition of CYP activities. Two types of mono-oxygenase reactions arylhydrocarbon h ydroxylase (AHH) and 7-methoxycoumarin-O-demethylase (MOCD) have been studi ed. Inhibition studies were investigated in rat microsomal fraction prepare d from untreated, 3MC- and PB- treated rat liver in vitro. Modifications we re introduced into the piperine molecule: (i) in the phenyl nucleus, (ii) i n the side chain and (iii) in the basic moiety. Thus, 38 compounds have bee n subjected to such studies, and simultaneously an attempt has also been ma de to arrive at the structure-activity relationship of synthetic analogues. In general, most of the inhibitory potential of the parent molecule is los t with modification in either of the three components of piperine. Saturati on of the side chain resulted in significantly enhanced inhibition of CYP w hile modifications in the phenyl and basic moieties in few analogues offere d maximal selectivity in inhibiting either constitutive or inducible CYP ac tivities. Thus Few novel analogues as CYP inactivators have been synthesize d which may have important consequences in pharmacokinetics and bioavailabi lity of drugs. (C) 2000 Elsevier Science Ltd. All rights reserved.